Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Published:2015-07-09 Issue:2 Volume:373 Page:123-135
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Brahmer Julie,Reckamp Karen L.,Baas Paul,Crinò Lucio,Eberhardt Wilfried E.E.,Poddubskaya Elena,Antonia Scott,Pluzanski Adam,Vokes Everett E.,Holgado Esther,Waterhouse David,Ready Neal,Gainor Justin,Arén Frontera Osvaldo,Havel Libor,Steins Martin,Garassino Marina C.,Aerts Joachim G.,Domine Manuel,Paz-Ares Luis,Reck Martin,Baudelet Christine,Harbison Christopher T.,Lestini Brian,Spigel David R.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1504627

Cited by 7025 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies for the treatment of colorectal cancer;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer;Neoplasia;2024-11

3. A Preliminary Study on the Correlation Between TILs and CTCs and Clinical Value in Lung Cancer Patients Analyzed by Lipid Magnetic Microspheres;Science of Advanced Materials;2024-11-01

4. Combined cryoablation and PD-1 inhibitor synergistically enhance antitumor immune responses in Lewis lung adenocarcinoma mice via the PI3K/AKT/mTOR pathway;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

5. The Adenosinergic Pathway in Non-Small Cell Lung Cancer;Cancers;2024-09-13